Since 2010, scientists have published an estimated 27,000 peer-reviewed papers specific to cannabis, with the annual number of total papers increasing every year. NORML’s Deputy Director Paul Armentano said, “It is time for politicians and others to stop assessing cannabis through the lens of ‘what we don’t know’ and instead start engaging in evidence-based discussions about marijuana and marijuana reform policies that are indicative of all that we do know.”
“What we see is that the trends in legal states like Colorado, Washington, Oregon and California are generally no different than the traffic safety trends in other states that haven’t changed their marijuana laws.”
Study: Enactment of Marijuana Legalization Laws Associated with Reductions in Opioid Prescribing Patterns
“[T]he implementation of medical marijuana laws (MMLs) and recreational marijuana laws (RMLs) reduced morphine milligram equivalents per enrollee by seven percent and 13 percent, respectively.”
Since 2010, scientists have published over 23,000 peer-reviewed papers on cannabis, with the annual number of papers increasing every year.
“Over the course of our study, … we identified a significant and progressive increase in the number of patients using cannabis. In patients with chronic pain, cannabis use more than doubled during this period.”
Review: Thousands Of Peer-Reviewed Studies Specific To Medical Cannabis Have Been Published Over Past Decade
The total number of peer-reviewed scientific papers dedicated to cannabis, and the therapeutic use of cannabis in particular, has increased exponentially in recent years, according to data published the journal Population Health Management. Authors identified just over 29,000 cannabis-centric scientific papers published during the study period, with over 3,300 of those dedicated to the subject of medical marijuana.
The National Academy of Sciences, Engineering, and Medicine released a comprehensive report today acknowledging that “conclusive or substantial evidence” exists for cannabis’ efficacy in patients suffering from chronic pain, and sharply criticized longstanding federal regulatory barriers to marijuana research – in particular “the classification of cannabis as a Schedule I substance” under federal law.
A new study on marijuana appeared in Journal of the American Heart Association. These are…